Tag: ANDA litigation
Federal Circuit Court: Authority on Pharmaceutical Patent Cases
The Federal Circuit Court has exclusive authority over pharmaceutical patent cases in the U.S., shaping drug access, pricing, and innovation through rulings on ANDA litigation, dosing patents, and jurisdiction. Its decisions directly impact generic drug entry and billions in healthcare spending.